Correlation Between Pyrophyte Acquisition and LAVA Medtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pyrophyte Acquisition and LAVA Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pyrophyte Acquisition and LAVA Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pyrophyte Acquisition Corp and LAVA Medtech Acquisition, you can compare the effects of market volatilities on Pyrophyte Acquisition and LAVA Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pyrophyte Acquisition with a short position of LAVA Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pyrophyte Acquisition and LAVA Medtech.

Diversification Opportunities for Pyrophyte Acquisition and LAVA Medtech

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Pyrophyte and LAVA is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Pyrophyte Acquisition Corp and LAVA Medtech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LAVA Medtech Acquisition and Pyrophyte Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pyrophyte Acquisition Corp are associated (or correlated) with LAVA Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LAVA Medtech Acquisition has no effect on the direction of Pyrophyte Acquisition i.e., Pyrophyte Acquisition and LAVA Medtech go up and down completely randomly.

Pair Corralation between Pyrophyte Acquisition and LAVA Medtech

Given the investment horizon of 90 days Pyrophyte Acquisition is expected to generate 1.16 times less return on investment than LAVA Medtech. But when comparing it to its historical volatility, Pyrophyte Acquisition Corp is 1.01 times less risky than LAVA Medtech. It trades about 0.15 of its potential returns per unit of risk. LAVA Medtech Acquisition is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  1,016  in LAVA Medtech Acquisition on August 30, 2024 and sell it today you would earn a total of  28.00  from holding LAVA Medtech Acquisition or generate 2.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy21.62%
ValuesDaily Returns

Pyrophyte Acquisition Corp  vs.  LAVA Medtech Acquisition

 Performance 
       Timeline  
Pyrophyte Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pyrophyte Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Pyrophyte Acquisition is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
LAVA Medtech Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LAVA Medtech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, LAVA Medtech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pyrophyte Acquisition and LAVA Medtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pyrophyte Acquisition and LAVA Medtech

The main advantage of trading using opposite Pyrophyte Acquisition and LAVA Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pyrophyte Acquisition position performs unexpectedly, LAVA Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LAVA Medtech will offset losses from the drop in LAVA Medtech's long position.
The idea behind Pyrophyte Acquisition Corp and LAVA Medtech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios